399 related articles for article (PubMed ID: 26597947)
1. More than the genes, the tumor microenvironment in neuroblastoma.
Borriello L; Seeger RC; Asgharzadeh S; DeClerck YA
Cancer Lett; 2016 Sep; 380(1):304-14. PubMed ID: 26597947
[TBL] [Abstract][Full Text] [Related]
2. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.
Maman S; Edry-Botzer L; Sagi-Assif O; Meshel T; Yuan W; Lu W; Witz IP
Int J Cancer; 2013 Nov; 133(10):2296-306. PubMed ID: 23649556
[TBL] [Abstract][Full Text] [Related]
3. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.
Murphy DM; Buckley PG; Bryan K; Watters KM; Koster J; van Sluis P; Molenaar J; Versteeg R; Stallings RL
Mol Carcinog; 2011 Jun; 50(6):403-11. PubMed ID: 21557326
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
[TBL] [Abstract][Full Text] [Related]
5. The Tumor Microenvironment in Neuroblastoma: New Players, New Mechanisms of Interaction and New Perspectives.
Blavier L; Yang RM; DeClerck YA
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050533
[TBL] [Abstract][Full Text] [Related]
6. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
[TBL] [Abstract][Full Text] [Related]
7. Dickkopf-3 expression is a marker for neuroblastic tumor maturation and is down-regulated by MYCN.
Koppen A; Ait-Aissa R; Koster J; Øra I; Bras J; van Sluis PG; Caron H; Versteeg R; Valentijn LJ
Int J Cancer; 2008 Apr; 122(7):1455-64. PubMed ID: 18059033
[TBL] [Abstract][Full Text] [Related]
8. Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma.
Wang J; Li H; Xue Y; Zhang Y; Ma X; Zhou C; Rong L; Zhang Y; Wang Y; Fang Y
Neoplasia; 2024 Jun; 52():100997. PubMed ID: 38669760
[TBL] [Abstract][Full Text] [Related]
9. N-myc and noncoding RNAs in neuroblastoma.
Buechner J; Einvik C
Mol Cancer Res; 2012 Oct; 10(10):1243-53. PubMed ID: 22936790
[TBL] [Abstract][Full Text] [Related]
10. A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.
Silverman AM; Nakata R; Shimada H; Sposto R; DeClerck YA
Cancer Res; 2012 May; 72(9):2228-38. PubMed ID: 22389450
[TBL] [Abstract][Full Text] [Related]
11. The quest to develop an effective therapy for neuroblastoma.
Bhoopathi P; Mannangatti P; Emdad L; Das SK; Fisher PB
J Cell Physiol; 2021 Nov; 236(11):7775-7791. PubMed ID: 33834508
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of invasion and metastasis in human neuroblastoma.
Ara T; DeClerck YA
Cancer Metastasis Rev; 2006 Dec; 25(4):645-57. PubMed ID: 17160711
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential.
Galardi A; Colletti M; Businaro P; Quintarelli C; Locatelli F; Di Giannatale A
Curr Med Chem; 2018 Feb; 25(5):584-600. PubMed ID: 28971761
[TBL] [Abstract][Full Text] [Related]
14. Biological Insight and Recent Advancement in the Treatment of Neuroblastoma.
Rivera Z; Escutia C; Madonna MB; Gupta KH
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37239815
[TBL] [Abstract][Full Text] [Related]
15. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest.
Yaari S; Jacob-Hirsch J; Amariglio N; Haklai R; Rechavi G; Kloog Y
Clin Cancer Res; 2005 Jun; 11(12):4321-30. PubMed ID: 15958613
[TBL] [Abstract][Full Text] [Related]
16. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Schramm A; Köster J; Marschall T; Martin M; Schwermer M; Fielitz K; Büchel G; Barann M; Esser D; Rosenstiel P; Rahmann S; Eggert A; Schulte JH
Int J Cancer; 2013 Feb; 132(3):E106-15. PubMed ID: 22907398
[TBL] [Abstract][Full Text] [Related]
17. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.
Middelbeek J; Visser D; Henneman L; Kamermans A; Kuipers AJ; Hoogerbrugge PM; Jalink K; van Leeuwen FN
Oncotarget; 2015 Apr; 6(11):8760-76. PubMed ID: 25797249
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles in neuroblastoma: role in progression, resistance to therapy and diagnostics.
Dhamdhere MR; Spiegelman VS
Front Immunol; 2024; 15():1385875. PubMed ID: 38660306
[TBL] [Abstract][Full Text] [Related]
19. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression.
Liu PY; Erriquez D; Marshall GM; Tee AE; Polly P; Wong M; Liu B; Bell JL; Zhang XD; Milazzo G; Cheung BB; Fox A; Swarbrick A; Hüttelmaier S; Kavallaris M; Perini G; Mattick JS; Dinger ME; Liu T
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906397
[TBL] [Abstract][Full Text] [Related]
20. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
